Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer

NCT00450203 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

1103

Enrollment

OTHER_GOV

Sponsor class

Conditions

Oesophagogastric Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: capecitabine
DRUG: cisplatin
DRUG: Epirubicin
PROCEDURE: adjuvant therapy
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy
DRUG: Lapatinib

Sponsor

Professor David Cunningham

Collaborators

[object Object]
[object Object]
[object Object]